12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements in Friday's pre-market session. Mural Oncology, Universe Pharmaceuticals, Biodesix, Allakos, SCWorx, and aTyr Pharma saw notable gains, while Avinger, Renovaro, Sage Therapeutics, Chromocell Therapeutics, Reshape Lifesciences, and BioCardia experienced declines.

October 04, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allakos shares increased by 12.38% to $0.75, indicating a positive market reaction.
The price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
aTyr Pharma shares moved up by 9.19% to $1.9, showing positive pre-market activity.
The upward movement suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Biodesix shares climbed 12.42% to $1.9, showing strong pre-market performance.
The upward movement suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Mural Oncology shares rose by 16.4% to $3.72, indicating strong investor interest.
The significant price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Universe Pharmaceuticals stock increased by 14.23% to $0.25, reflecting positive market sentiment.
The rise in stock price indicates a positive outlook, potentially due to favorable news or investor interest.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
SCWorx stock rose by 11.41% to $1.25, reflecting positive investor sentiment.
The increase in stock price indicates a positive outlook, potentially due to favorable news or investor interest.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Avinger stock declined by 17.1% to $1.07, indicating negative market sentiment.
The significant price drop suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
BioCardia shares declined by 7.83% to $2.59, showing negative pre-market activity.
The downward movement suggests negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Chromocell Therapeutics shares decreased by 10.3% to $0.61, indicating negative market reaction.
The price decrease suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Renovaro shares fell 12.49% to $0.44, reflecting negative investor sentiment.
The decline in stock price indicates a negative outlook, potentially due to unfavorable news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Reshape Lifesciences stock decreased by 7.86% to $4.66, reflecting negative investor sentiment.
The decline in stock price indicates a negative outlook, potentially due to unfavorable news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Sage Therapeutics stock decreased by 11.28% to $6.2, showing negative pre-market performance.
The downward movement suggests negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75